Company

Biotron Limited

Headquarters: North Ryde, NSW, Australia

ASX: BIT -2.56%

Market Cap

A$35.2 Million

AUD as of July 1, 2024

US$23.4 Million

Market Cap History

Biotron Limited market capitalization over time

Evolution of Biotron Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Biotron Limited

Detailed Description

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also develops a portfolio of preclinical antiviral drugs. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Biotron Limited has the following listings and related stock indices.


Stock: ASX: BIT wb_incandescent

Details

Headquarters:

56 Delhi Road

Suite 3.3

North Ryde, NSW 2113

Australia

Phone: 61 2 9805 0488

Fax: 61 2 9805 0688